poly- beta- (D- galactopyranosyl)- poly- D- lysine

substrate for tissue culture of embryonic mouse cerebellar cells

Also Known As:

PG-PL

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Galactans: 56
    - poly-beta-(D-galactopyranosyl)-poly-D-lysine: 3
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Polylysine: 237
    - poly-beta-(D-galactopyranosyl)-poly-D-lysine: 3
- Amino Acids: 30675
  - Basic Amino Acids: 178
    - Lysine: 6737
      - Polylysine: 237
        poly-beta-(D-galactopyranosyl)-poly-D-lysine: 3
  - Diamino Amino Acids: 101
    - Lysine: 6737
      - Polylysine: 237
        poly-beta-(D-galactopyranosyl)-poly-D-lysine: 3

Experts

1.	Bao, Seraph: 1 article (12/2020)
2.	Beyzaei, Nadia: 1 article (12/2020)
3.	Bu, Yanyun: 1 article (12/2020)
4.	Chan, Melvin: 1 article (12/2020)
5.	Garn, Heinrich: 1 article (12/2020)
6.	Hung, Linus: 1 article (12/2020)
7.	Hussaina, Hebah: 1 article (12/2020)
8.	Ipsiroglu, Osman S: 1 article (12/2020)
9.	Kloesch, Gerhard: 1 article (12/2020)
10.	Kohn, Bernhard: 1 article (12/2020)

Related Diseases

1.	Dry Eye Syndromes (Dry Eye Syndrome) 03/10/2017 - "To evaluate and compare the efficacy of a lipid-based lubricant eyedrop formulation (hydroxypropyl guar/propylene glycol/phospholipid [HPG/PG/PL]) with preservative-free saline for the treatment of dry eye. "
2.	Chronic Obstructive Pulmonary Disease (COPD) 05/01/2007 - "Plasma levels of IL-18 were elevated in COPD patients (n = 20) versus healthy controls (n = 20) (221.2 pg/ml [196.0-294.2 pg/pl] vs. 164.8 pg/ml [144.4-193.3 pg/pl], p = 0.05) [corrected] and IL-18 was expressed in skeletal muscle, with IL-18 mRNA levels being elevated in biopsies from COPD patients (n = 19) versus healthy controls (n = 18) (4.3 [2.6-5.9] vs. 2.4 [1.6-3.1], p = 0.05) [corrected]. "
3.	Restless Legs Syndrome (Restless Legs) 12/01/2020 - "As Attention Deficit Hyperactivity Disorder, Restless Legs syndrome/Willis Ekbom disease and medication induced activation syndromes (including increased irritability and/or akathisia), present with hyperactive-behaviors with hyper-arousability and/or hypermotor-restlessness (H-behaviors), we first developed a non-interpretative, neutral pictogram-guided phenotyping language (PG-PL) for describing body-segment movements during sitting. "
4.	Psychomotor Agitation (Akathisia) 12/01/2020 - "As Attention Deficit Hyperactivity Disorder, Restless Legs syndrome/Willis Ekbom disease and medication induced activation syndromes (including increased irritability and/or akathisia), present with hyperactive-behaviors with hyper-arousability and/or hypermotor-restlessness (H-behaviors), we first developed a non-interpretative, neutral pictogram-guided phenotyping language (PG-PL) for describing body-segment movements during sitting. "
5.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/01/2020 - "As Attention Deficit Hyperactivity Disorder, Restless Legs syndrome/Willis Ekbom disease and medication induced activation syndromes (including increased irritability and/or akathisia), present with hyperactive-behaviors with hyper-arousability and/or hypermotor-restlessness (H-behaviors), we first developed a non-interpretative, neutral pictogram-guided phenotyping language (PG-PL) for describing body-segment movements during sitting. "

Related Drugs and Biologics

1.	Lubricants
2.	Propylene Glycol (1,2 Propanediol)
3.	Phospholipids (Phosphatides)
4.	Ophthalmic Solutions (Eye Drops)
5.	Lipids
6.	hydroxypropyl guar
7.	Interleukin-18 (Interleukin 18)
8.	Messenger RNA (mRNA)